Aspiriant LLC’s Vanguard FTSE Pacific ETF VPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Hold
2,611
0.01% 316
2026
Q1
$255K Hold
2,611
0.01% 303
2025
Q4
$236K Buy
+2,611
New +$236K 0.01% 302
2018
Q2
Sell
-4,500
Closed -$328K 263
2018
Q1
$328K Buy
+4,500
New +$333K 0.03% 186
2017
Q4
Sell
-4,500
Closed -$307K 180
2017
Q3
$307K Hold
4,500
0.03% 163
2017
Q2
$296K Sell
4,500
-150
-3% -$9.7K 0.03% 172
2017
Q1
$294K Buy
4,650
+150
+3% +$9.28K 0.03% 174
2016
Q4
$262K Hold
4,500
0.02% 167
2016
Q3
$273K Buy
+4,500
New +$265K 0.03% 164

Other funds holding VPL

Aspiriant LLC's VPL Position: Q2 2026 in Review

Aspiriant LLC held its Vanguard FTSE Pacific ETF (VPL) position steady in Q2 2026 at 2,611 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #316.

Aspiriant LLC first reported a position in VPL in Q3 2016 and has held it in 9 quarters since. The position peaked at $328K in Q1 2018. 455 funds tracked by Wall St. Rank hold VPL as of Q2 2026.

  • Aspiriant LLC held 2,611 shares of Vanguard FTSE Pacific ETF worth $302K as of Q2 2026.
  • Aspiriant LLC left its Vanguard FTSE Pacific ETF share count unchanged in Q2 2026.
  • Vanguard FTSE Pacific ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #316 holding.
  • Aspiriant LLC first reported a position in Vanguard FTSE Pacific ETF in Q3 2016 and has held it in 9 quarters since.
  • Aspiriant LLC's Vanguard FTSE Pacific ETF position peaked at $328K in Q1 2018.
  • 455 funds tracked by Wall St. Rank held Vanguard FTSE Pacific ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.